What does NEXTBio Capital Management LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

NEXTBio Capital Management LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

TERNS PHARMACEUTICALS INC

$32M605K14.8%

PROTAGONIST THERAPEUTICS INC

$24M230K11.2%

SHATTUCK LABS INC

$20M3.1M9.4%

VOR BIOPHARMA INC

$18M1000K8.3%

COMPASS PATHWAYS PLC

$11M2.0M5.2%

RHYTHM PHARMACEUTICALS INC

$11M126K5.1%

XENON PHARMACEUTICALS INC

$11M183K4.9%

PALVELLA THERAPEUTICS INC NE

$10M83K4.8%

ZENAS BIOPHARMA INC

$8M427K3.9%

INVENTIVA SA

$7M1.3M3.4%

Filing history loading…